Treatment of acute respiratory infection in adults: results of a multicenter randomized double-blind placebo-controlled clinical trial

Treatment of acute respiratory infection in adults: results of a multicenter randomized double-blind placebo-controlled clinical trial

The results of a multicenter randomized double-blind placebo-controlled clinical trial in parallel groups carried out in 2012–2015 aimed to reveal the efficacy and safety of the antiviral drug ergoferon in the treatment of acute respiratory tract infection in adults are presented.

Saved in:
Bibliographic Details
Main Authors: M. P. Kostinov, R. F. Khamitov, A. P. Babkin, E. S. Minina, B. Ya. Bart, M. P. Mikhailusova, M. E. Yanovskaya, A. O. Sherenkov, D. V. Petrov, D. N. Alpenidze, Yu. S. Shapovalova, M. V. Chernogorova, E. F. Pavlysh, R. T. Sardinov
Format: Article
Language:Russian
Published: Open Systems Publication 2021-06-01
Series:Лечащий Врач
Subjects:
upper respiratory tract infection
placebo-controlled study
acute respiratory tract infection
treatment
Online Access:https://journal.lvrach.ru/jour/article/view/287
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journal.lvrach.ru/jour/article/view/287

Similar Items